<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.harmreductionjournal.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Harm Reduction Journal - Most accessed articles</title>
        <link>http://www.harmreductionjournal.com</link>
        <description>The most accessed research articles published by Harm Reduction Journal</description>
        <dc:date>2012-04-02T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/9/1/16" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/5/1/19" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/2/1/11" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/1/1/5" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/2/1/21" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/4/1/16" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/4/1/11" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/9/1/15" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/2/1/17" />
                                <rdf:li rdf:resource="http://www.harmreductionjournal.com/content/6/1/6" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.harmreductionjournal.com/content/9/1/16">
        <title>Language acquisition for deaf children: Reducing the harms of zero tolerance to the use of alternative approaches</title>
        <description>Children acquire language without instruction as long as they are regularly and meaningfully engaged with an accessible human language. Today, 80% of children born deaf in the developed world are implanted with cochlear devices that allow some of them access to sound in their early years, which helps them to develop speech. However, through early childhood, brain plasticity changes and children who have not acquired a first language in the early years might never be completely fluent in any language. If they miss this critical period for exposure to a natural language, their subsequent development of the cognitive activities that rely on a solid first language might be underdeveloped, such as literacy, memory organization, and number manipulation. An alternative to speech-exclusive approaches to language acquisition exists in the use of sign languages such as American Sign Language (ASL), where acquiring a sign language is subject to the same time constraints of spoken language development. Unfortunately, so far, these alternatives are caught up in an &quot;either - or&quot; dilemma, leading to a highly polarized conflict about which system families should choose for their children, with little tolerance for alternatives by either side of the debate and widespread misinformation about the evidence and implications for or against either approach. The success rate with cochlear implants is highly variable. This issue is still debated, and as far as we know, there are no reliable predictors for success with implants. Yet families are often advised not to expose their child to sign language. Here absolute positions based on ideology create pressures for parents that might jeopardize the real developmental needs of deaf children. What we do know is that cochlear implants do not offer accessible language to many deaf children. By the time it is clear that the deaf child is not acquiring spoken language with cochlear devices, it might already be past the critical period, and the child runs the risk of becoming linguistically deprived. Linguistic deprivation constitutes multiple personal harms as well as harms to society (in terms of costs to our medical systems and in loss of potential productive societal participation).</description>
        <link>http://www.harmreductionjournal.com/content/9/1/16</link>
                <dc:creator>Tom Humphries</dc:creator>
                <dc:creator>Poorna Kushalnagar</dc:creator>
                <dc:creator>Gaurav Mathur</dc:creator>
                <dc:creator>Donna Jo Napoli</dc:creator>
                <dc:creator>Carol Padden</dc:creator>
                <dc:creator>Christian Rathmann</dc:creator>
                <dc:creator>Scott Smith</dc:creator>
                <dc:source>Harm Reduction Journal 2012, null:16</dc:source>
        <dc:date>2012-04-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-9-16</dc:identifier>
                                <prism:require>/content/figures/1477-7517-9-16-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2012-04-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/5/1/19">
        <title>Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers</title>
        <description>Background:
We have recently published some work on CEA levels in hookah (also called narghile, shisha elsewhere) and cigarette smokers. Hookah smokers had higher levels of CEA than non-smokers although mean levels were low compared to cigarette smokers. However some of them were also users of other tobacco products (cigarettes, bidis, etc.).ObjectivesTo find serum CEA levels in ever/exclusive hookah smokers, i.e. those who smoked only hookah (no cigarettes, bidis, etc.), prepared between 1 and 4 times a day with a quantity of up to 120 g of a tobacco-molasses mixture each (i.e. the tobacco weight equivalent of up to 60 cigarettes of 1 g each) and consumed in 1 to 8 sessions.
Methods:
Enhanced chemiluminescent immunometric technique was applied to measure CEA levels in serum samples from 59 exclusive male smokers with age ranging from 20&#8211;80 years (mean = 58.8 &#177; 14.7 years) and 8&#8211;65 years of smoking (mean = 37.7 &#177; 16.8). 36 non-smokers served as controls. Subjects were divided into 3 groups according to the number of preparations; the number of sessions and the total daily smoking time: Light (1; 1; &#8804; 20 minutes); Medium (1&#8211;3; 1&#8211;3; &gt;20 min to &#8804; 2 hrs) and Heavy smokers (2&#8211;4; 3&#8211;8; &gt;2 hrs to &#8804; 6 hrs). Because of the nature of distribution of CEA levels among our individuals, Wilcoxon&apos;s rank sum two-sample test was applied to compare the variables.
Results:
The overall CEA levels in exclusive hookah smokers (mean: 3.58 &#177; 2.61 ng/ml; n = 59) were not significantly different (p &#8804; 0.0937) from the levels in non-smokers (2.35 &#177; 0.71 ng/ml). Mean levels in light, medium and heavy smokers were: 1.06 &#177; 0.492 ng/ml (n = 5); 2.52 &#177; 1.15 ng/ml (n = 28) and 5.11 &#177; 3.08 ng/ml (n = 26) respectively. The levels in medium smokers and non-smokers were also not significantly different (p &#8804; 0.9138). In heavy smokers, the CEA levels were significantly higher than in non-smokers (p &#8804; 0.0001567).
Conclusion:
Overall CEA levels in exclusive hookah smokers were low compared to cigarette smokers. However, heavy hookah smoking substantially raises CEA levels. Low-nitrosamines smokeless tobacco of the SNUS Swedish type could be envisaged as an alternative to smoking for this category of users and also, in a broad harm reduction perspective, to the prevalent low-quality moist snuff called naswar.</description>
        <link>http://www.harmreductionjournal.com/content/5/1/19</link>
                <dc:creator>Khan Sajid</dc:creator>
                <dc:creator>Kamal Chaouachi</dc:creator>
                <dc:creator>Rubaida Mahmood</dc:creator>
                <dc:source>Harm Reduction Journal 2008, null:19</dc:source>
        <dc:date>2008-05-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-5-19</dc:identifier>
                                <prism:require>/content/figures/1477-7517-5-19-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2008-05-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/2/1/11">
        <title>A case report: Pavlovian conditioning as a risk factor of heroin &apos;overdose&apos; death</title>
        <description>Background:
The authors present a case illustrating a mechanism leading directly to death which is not rare but has received little attention.Case presentationThe case was evaluated by autopsy, investigation of morphine concentration in the blood, and clinical data. The heroin dose causing the &apos;overdose&apos; death of a young man who had previously been treated a number of times for heroin addiction did not differ from his dose of the previous day taken in the accustomed circumstances. The accustomed dose taken in a strange environment caused fatal complications because the conditioned tolerance failed to operate. The concentration of morphine in the blood did not exceed the level measured during earlier treatment.
Conclusion:
These results are in line with the data in the literature indicating that morphine concentrations measured in cases of drug-related death do not differ substantially from those measured in cases where the outcome is not fatal. A knowledge of the conditioning mechanism can contribute to prevention of fatal cases of a similar type. The harm reduction approach places great stress on preventive intervention based on data related to drug-related death.</description>
        <link>http://www.harmreductionjournal.com/content/2/1/11</link>
                <dc:creator>Jozsef Gerevich</dc:creator>
                <dc:creator>Erika Bacskai</dc:creator>
                <dc:creator>Lajos Farkas</dc:creator>
                <dc:creator>Zoltan Danics</dc:creator>
                <dc:source>Harm Reduction Journal 2005, null:11</dc:source>
        <dc:date>2005-07-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-2-11</dc:identifier>
                                <prism:require>/content/figures/1477-7517-2-11-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2005-07-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/1/1/5">
        <title>Substance use during pregnancy: time for policy to catch up with research</title>
        <description>The phenomenon of substance abuse during pregnancy has fostered much controversy, specifically regarding treatment vs. punishment. Should the pregnant mother who engages in substance abuse be viewed as a criminal or as someone suffering from an illness requiring appropriate treatment? As it happens, there is a noticeably wide range of responses to this matter in the various states of the United States, ranging from a strictly criminal perspective to one that does emphasize the importance of the mother&apos;s treatment. This diversity of dramatically different responses illustrates the failure to establish a uniform policy for the management of this phenomenon. Just as there is lack of consensus among those who favor punishment, the same lack of consensus characterizes those states espousing treatment. Several general policy recommendations are offered here addressing the critical issues. It is hoped that by focusing on these fundamental issues and ultimately detailing statistics, policymakers throughout the United States will consider the course of action that views both pregnant mother and fetus/child as humanely as possible.</description>
        <link>http://www.harmreductionjournal.com/content/1/1/5</link>
                <dc:creator>Barry Lester</dc:creator>
                <dc:creator>Lynne Andreozzi</dc:creator>
                <dc:creator>Lindsey Appiah</dc:creator>
                <dc:source>Harm Reduction Journal 2004, null:5</dc:source>
        <dc:date>2004-04-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-1-5</dc:identifier>
                                <prism:require>/content/figures/1477-7517-1-5-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2004-04-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/2/1/21">
        <title>Cannabis and tobacco smoke are not equally carcinogenic</title>
        <description>More people are using the cannabis plant as modern basic and clinical science reaffirms and extends its medicinal uses. Concomitantly, concern and opposition to smoked medicine has occurred, in part due to the known carcinogenic consequences of smoking tobacco. Are these reactions justified? While chemically very similar, there are fundamental differences in the pharmacological properties between cannabis and tobacco smoke. Cannabis smoke contains cannabinoids whereas tobacco smoke contains nicotine. Available scientific data, that examines the carcinogenic properties of inhaling smoke and its biological consequences, suggests reasons why tobacco smoke, but not cannabis smoke, may result in lung cancer.</description>
        <link>http://www.harmreductionjournal.com/content/2/1/21</link>
                <dc:creator>Robert Melamede</dc:creator>
                <dc:source>Harm Reduction Journal 2005, null:21</dc:source>
        <dc:date>2005-10-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-2-21</dc:identifier>
                                <prism:require>/content/figures/1477-7517-2-21-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2005-10-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/4/1/16">
        <title>Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants</title>
        <description>Background:
Cannabis (marijuana) had been used for medicinal purposes for millennia. Cannabinoid agonists are now attracting growing interest and there is also evidence that botanical cannabis is being used as self-medication for stress and anxiety as well as adjunctive therapy by the seriously ill and by patients with terminal illnesses. California became the first state to authorize medicinal use of cannabis in 1996, and it was recently estimated that between 250,000 and 350,000 Californians may now possess the physician&apos;s recommendation required to use it medically. More limited medical use has also been approved in 12 additional states and new initiatives are being considered in others. Despite that evidence of increasing public acceptance of &quot;medical&quot; use, a definitional problem remains and all use for any purpose is still prohibited by federal law.
Results:
California&apos;s 1996 initiative allowed cannabis to be recommended, not only for serious illnesses, but also &quot;for any other illness for which marijuana provides relief,&quot; thus maximally broadening the range of allowable indications. In effect, the range of conditions now being treated with federally illegal cannabis, the modes in which it is being used, and the demographics of the population using it became potentially discoverable through the required screening of applicants. This report examines the demographic profiles and other selected characteristics of 4117 California marijuana users (62% from the Greater Bay Area) who applied for medical recommendations between late 2001 and mid 2007.
Conclusion:
This study yielded a somewhat unexpected profile of a hitherto hidden population of users of America&apos;s most popular illegal drug. It also raises questions about some of the basic assumptions held by both proponents and opponents of current policy.</description>
        <link>http://www.harmreductionjournal.com/content/4/1/16</link>
                <dc:creator>Thomas O'Connell</dc:creator>
                <dc:creator>Che Bou-Matar</dc:creator>
                <dc:source>Harm Reduction Journal 2007, null:16</dc:source>
        <dc:date>2007-11-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-4-16</dc:identifier>
                            <dc:title>Long-term marijuana use for medicinal purposes</dc:title>
                            <dc:description>Analysis of the demographic and social characteristics of 4117 long term marijuana users in California, who applied for a physician&apos;s recommendation to use cannabis, indicates that long-term use at modest levels may be non-problematic. </dc:description>
                <prism:require>/content/figures/1477-7517-4-16-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2007-11-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/4/1/11">
        <title>Decreased respiratory symptoms in cannabis users who vaporize</title>
        <description>Cannabis smoking can create respiratory problems. Vaporizers heat cannabis to release active cannabinoids, but remain cool enough to avoid the smoke and toxins associated with combustion. Vaporized cannabis should create fewer respiratory symptoms than smoked cannabis. We examined self-reported respiratory symptoms in participants who ranged in cigarette and cannabis use. Data from a large Internet sample revealed that the use of a vaporizer predicted fewer respiratory symptoms even when age, sex, cigarette smoking, and amount of cannabis used were taken into account. Age, sex, cigarettes, and amount of cannabis also had significant effects. The number of cigarettes smoked and amount of cannabis used interacted to create worse respiratory problems. A significant interaction revealed that the impact of a vaporizer was larger as the amount of cannabis used increased. These data suggest that the safety of cannabis can increase with the use of a vaporizer. Regular users of joints, blunts, pipes, and water pipes might decrease respiratory symptoms by switching to a vaporizer</description>
        <link>http://www.harmreductionjournal.com/content/4/1/11</link>
                <dc:creator>Mitch Earleywine</dc:creator>
                <dc:creator>Sara Smucker Barnwell</dc:creator>
                <dc:source>Harm Reduction Journal 2007, null:11</dc:source>
        <dc:date>2007-04-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-4-11</dc:identifier>
                            <dc:title>Vaporizer reduces harm to marijuana users</dc:title>
                            <dc:description>Marijuana smokers, who often report respiratory problems such as coughing or shortness of breath, present fewer of these symptoms when using a vaporizer, a device that heats marijuana to release the active ingredients.</dc:description>
                <prism:require>/content/figures/1477-7517-4-11-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2007-04-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/9/1/15">
        <title>Correlates to the variable effects of cannabis in young adults: a preliminary study</title>
        <description>Background:
Cannabis use can frequently have adverse affects in those that use it and these can be amplified by various characteristics of an individual, from demographic and environmental variations to familial predisposition for mental illnesses.
Methods:
The current study of 100 individuals, who were cannabis users during their adolescence and may still be users, was a survey of the self perceived effects of cannabis and their correlates. A reliable family member was also interviewed for determination of family history of various major mental illnesses and substance use.
Results:
As many as 40% of cannabis users had paranoid feelings (suspiciousness) when using cannabis, although the most frequent effect was feeling relaxed (46%). Having a familial background for mental illnesses such as depression or schizophrenia did not determine the effects of cannabis nor its pattern of use, although the number of subjects with such a history was small. An age at which an individual began using cannabis did have an effect on how heavily it was used and the heavier the cannabis use, the more likely the individual was also to have had psychotic symptoms after use. There were no sex differences in effects of cannabis. These results are tempered by the reliance on self-report for many of the variables ascertained.
Conclusion:
Cannabis can frequently have negative effects in its users, which can be amplified by certain demographic and/or psychosocial factors. Thus, users with a specific profile may be at a higher risk of unpleasant effects from cannabis use and caution should be noted when cannabis is administered to young people for medicinal purposes.</description>
        <link>http://www.harmreductionjournal.com/content/9/1/15</link>
                <dc:creator>Ariella Camera</dc:creator>
                <dc:creator>Veronica Tomaselli</dc:creator>
                <dc:creator>Jerry Fleming</dc:creator>
                <dc:creator>Gul Jabbar</dc:creator>
                <dc:creator>Melissa Trachtenberg</dc:creator>
                <dc:creator>Juan Galvez-Buccollini</dc:creator>
                <dc:creator>Ashley Proal</dc:creator>
                <dc:creator>Richard Rosenthal</dc:creator>
                <dc:creator>Lynn DeLisi</dc:creator>
                <dc:source>Harm Reduction Journal 2012, null:15</dc:source>
        <dc:date>2012-03-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-9-15</dc:identifier>
                                <prism:require>/content/figures/1477-7517-9-15-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2012-03-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/2/1/17">
        <title>Harm reduction-the cannabis paradox</title>
        <description>This article examines harm reduction from a novel perspective. Its central thesis is that harm reduction is not only a social concept, but also a biological one. More specifically, evolution does not make moral distinctions in the selection process, but utilizes a cannabis-based approach to harm reduction in order to promote survival of the fittest. Evidence will be provided from peer-reviewed scientific literature that supports the hypothesis that humans, and all animals, make and use internally produced cannabis-like products (endocannabinoids) as part of the evolutionary harm reduction program. More specifically, endocannabinoids homeostatically regulate all body systems (cardiovascular, digestive, endocrine, excretory, immune, nervous, musculo-skeletal, reproductive). Therefore, the health of each individual is dependant on this system working appropriately.</description>
        <link>http://www.harmreductionjournal.com/content/2/1/17</link>
                <dc:creator>Robert Melamede</dc:creator>
                <dc:source>Harm Reduction Journal 2005, null:17</dc:source>
        <dc:date>2005-09-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-2-17</dc:identifier>
                                <prism:require>/content/figures/1477-7517-2-17-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2005-09-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.harmreductionjournal.com/content/6/1/6">
        <title>Overdose beliefs and management practices among ethnic Vietnamese heroin users in Sydney, Australia</title>
        <description>Background:
Ethnic Vietnamese injecting drug users (IDUs) in Australia draw on a range of beliefs and etiologic models, sometimes simultaneously, in order to make sense of health and illness. These include understandings of illness as the result of internal imbalances and Western concepts of disease causation including germ/pollution theory.
Methods:
Observational fieldwork and in-depth interviews were conducted between 2001 and 2006 in neighbourhoods characterised by high proportions of Asian background IDUs and street-based drug markets. Eligibility criteria for the study were: 1) ethnic Vietnamese cultural background; 2) aged 16 years and over and; 3) injected drugs in the last 6 months.
Results:
Participants commonly attempted to treat heroin overdose by withdrawing blood (r&#250;t m&#225;u) from the body. Central to this practice are cultural beliefs about the role and function of blood in the body and its relationship to illness and health. Participants&apos; beliefs in blood were strongly influenced by understandings of blood expressed in traditional Chinese and Vietnamese medicine. Many participants perceived Western drugs, particularly heroin, as &quot;hot&quot; and &quot;strong&quot;. In overdose situations, it was commonly believed that an excessive amount of drugs (particularly heroin) entered the bloodstream and traveled to the heart, making the heart work too hard. Withdrawing blood was understood to reduce the amount of drugs in the body which in turn reduced the effects of drugs on the blood and the heart.
Conclusion:
The explanatory model of overdose employed by ethnic Vietnamese IDUs privileges traditional beliefs about the circulatory, rather than the respiratory, system. This paper explores participants&apos; beliefs about blood, the effects of drugs on blood and the causes of heroin overdose in order to document the explanatory model of overdose used by ethnic Vietnamese IDUs. Implications for overdose prevention, treatment and management are identified and discussed.</description>
        <link>http://www.harmreductionjournal.com/content/6/1/6</link>
                <dc:creator>Lisa Maher</dc:creator>
                <dc:creator>Hien Ho</dc:creator>
                <dc:source>Harm Reduction Journal 2009, null:6</dc:source>
        <dc:date>2009-04-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-7517-6-6</dc:identifier>
                                <prism:require>/content/figures/1477-7517-6-6-toc.gif</prism:require>
                <prism:publicationName>Harm Reduction Journal</prism:publicationName>
        <prism:issn>1477-7517</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-04-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

